Brief: Cytodyn Completes Enrollment For Phase 3 Registrational Trial For 390 Patients With Severe-To-Critical Covid-19

Cytodyn

15/12/2020 21:39

Dec 15 (Reuters) - Cytodyn Inc  CYDY.PK :
    * CYTODYN COMPLETES ENROLLMENT FOR PHASE 3 REGISTRATIONAL
TRIAL
FOR 390 PATIENTS WITH SEVERE-TO-CRITICAL COVID-19
    * CYTODYN INC - 390-PATIENT DATA WILL BE ANALYZED IN
APPROXIMATELY
28 DAYS, WITH EXPECTED RESULTS TO BE ANNOUNCED SHORTLY
THEREAFTER

Source text for Eikon:  ID:nGNXb6BDsd 
Further company coverage:  CYDY.PK 

 ((Reuters.Briefs@thomsonreuters.com;))